Sex hormones and colorectal cancer: what have we learned so far?
Jennifer H
JH
Lin
Edward
E
Giovannucci
D000726:Androgen Antagonists / Q000008:administration & dosage / Q000009:adverse effects; D016588:Anticarcinogenic Agents / Q000008:administration & dosage*; D015179:Colorectal Neoplasms / Q000378:metabolism / Q000517:prevention & control*; D004334:Drug Administration Schedule; D019008:Drug Resistance, Neoplasm; D004967:Estrogens / Q000008:administration & dosage; D005260:Female; D012739:Gonadal Steroid Hormones / Q000008:administration & dosage* / Q000009:adverse effects* / Q000378:metabolism; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D008019:Life Style; D008297:Male; D009376:Neoplasms, Hormone-Dependent / Q000378:metabolism / Q000517:prevention & control*; D009919:Orchiectomy / Q000009:adverse effects; D011374:Progesterone / Q000008:administration & dosage; D012307:Risk Factors; D012737:Sex Factors; D013997:Time Factors
D000726:Androgen Antagonists; D016588:Anticarcinogenic Agents; D004967:Estrogens; D012739:Gonadal Steroid Hormones; D007987:Gonadotropin-Releasing Hormone; D011374:Progesterone